Back to Search
Start Over
Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
- Source :
- npj Breast Cancer, Vol 10, Iss 1, Pp 1-1 (2024)
- Publication Year :
- 2024
- Publisher :
- Nature Portfolio, 2024.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 23744677
- Volume :
- 10
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- npj Breast Cancer
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.bb00ee86ac244e6959147aeb2f4a725
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41523-024-00650-6